79 results
P
chronic respiratory disease (CRD) individuals
I/C
greenness exposure, no greenness exposure
O
lower rates of asthma incidence, lung cancer incidence, and chronic obstructive pulmonary disease (COPD) mortality risk
P
residents
I/C
residential green and blue spaces, no residential green and blue spaces
O
pregnancy outcomes, birth weight, small for gestational age, low birth weight, preterm birth
P
11,983,089 participants
I/C
Residential greenness exposure, Highest level of greenness exposure group compared to lowest level group
O
Birth weight, low birth weight (LBW), small for gestational age (SGA), head circumference, mental disorders
P
prostate cancer patients
I/C
indocyanine green fluorescence, histopathologic findings in the dissected specimen
O
diagnostic performance of indocyanine green fluorescence in detecting lymph node metastasis
P
women with polycystic ovary syndrome (PCOS)
I/C
green tea supplementation, placebo
O
body weight (kg)
P
493 332
I/C
green tea consumption, no association
O
risk for esophageal cancer (EC)
P
East Asia
I/C
green tea consumption, nonconsumers
O
reduced risk of CHD
P
healthy and/or with disease types
I/C
green cardamom supplementation, control group
O
triglycerides levels, BMI, total cholesterol, LDL-cholesterol, HDL-cholesterol, fasting plasma glucose, body weight
P
low-risk endometrial cancer, intermediate-risk endometrial cancer
I/C
indocyanine green (ICG), no SLN mapping
O
high detection rate, negative predictive value
P
patients undergoing total gastrectomy for gastric cancer
I/C
J-pouch (JP) reconstruction, standard Roux-en-Y (RY) esophagojejunostomy
O
dumping syndrome, heartburn symptoms